COMBINATION OF LENVATINIB AND PEMBROLISUMAB IN THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER: A CASE REPORT

COMBINATION OF LENVATINIB AND PEMBROLISUMAB IN THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER: A CASE REPORT

Background. Endometrial cancer is the most common malignancy of the female reproductive system. Patients with metastatic endometrial cancer have the overall 5-year survival rate of less than 20 %. The efficacy of treatment of advanced endometrial cancer remains low; therefore, the search for novel a...

Full description

Bibliographic Details
Main Authors:	O. N. Churuksaeva, L. A. Kolomiets, A. B. Villert
Format:	Article
Language:	Russian
Published:	Tomsk National Research Medical Center of the Russian Academy of Sciences 2021-03-01
Series:	Sibirskij Onkologičeskij Žurnal
Subjects:	endometrial cancer microsatellite instability msi disruption in the repair system mmr chemotherapy lenvatinib pembrolizumab
Online Access:	https://www.siboncoj.ru/jour/article/view/1705

Similar Items

Lenvatinib and pembrolizumab in patients with advanced uterine cancer
by: A. G. Kedrova, et al.
Published: (2021-01-01)

Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
by: Sherry Shen, et al.
Published: (2021-08-01)

Mismatch Repair Pathway, Genome Stability and Cancer
by: Nives Pećina-Šlaus, et al.
Published: (2020-06-01)

Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
by: Alaa Salah Jumaah, et al.
Published: (2021-05-01)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
by: Jonathan T. Hunt, et al.
Published: (2021-08-01)

Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report
by: Zhaonan Liu, et al.
Published: (2019-11-01)

Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report
by: Makoto Nakagawa, et al.
Published: (2021-08-01)

The contribution of Lynch syndrome to early onset malignancy in Ireland
by: Alice Talbot, et al.
Published: (2021-05-01)

The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
by: Yun Wang, et al.
Published: (2020-12-01)

Microsatellite instability: a review of what the oncologist should know
by: Kai Li, et al.
Published: (2020-01-01)

Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
by: Konstantinos Venetis, et al.
Published: (2021-09-01)

The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review
by: Maria Cilona, et al.
Published: (2020-10-01)

Molecular genetic approach for screening of hereditary non-polyposis colorectal cancer
by: Metka Ravnik-Glavač
Published: (2005-07-01)

Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
by: T. T. Andabekov, et al.
Published: (2019-07-01)

Rapid regression of microsatellite instability-high/programmed cell death ligand 1-negative recurrent endometrial carcinoma by immune checkpoint blockade with pembrolizumab: A case report and literature review
by: Akihiro Takeda, et al.
Published: (2020-05-01)

Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian)
by: Camille Evrard, et al.
Published: (2021-05-01)

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
by: Michael M. Boyiadzis, et al.
Published: (2018-05-01)

Pancytopenia And Limbic Encephalopathy Complicating Immunotherapy For Clear Cell Endometrial Cancer With Microsatellite Instability-High (MSI-H)
by: Kanbour A, et al.
Published: (2019-11-01)

Towards a molecular classification of colorectal cancer:The role of microsatellite instability status
by: Karl eHeinimann
Published: (2013-10-01)

Case Report: Significant Response to the Combination of Lenvatinib and Immune Checkpoint Inhibitor in a Patient With Heavily Pretreated Metastatic Triple Negative Breast Cancer
by: Jin Sun Lee, et al.
Published: (2021-01-01)

Impact of microsatellite instability on survival of endometrial cancer patients
by: Daiva Kanopienė, et al.
Published: (2014-01-01)

Microsatellite instability in prostate cancer by PCR or next-generation sequencing
by: Jennifer A. Hempelmann, et al.
Published: (2018-04-01)

Endometrial cancer and microsatellite instability status
by: Kanopiene Daiva, et al.
Published: (2014-11-01)

Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High
by: Kawai K, et al.
Published: (2021-09-01)

What is currently known about endometrial cancer in Lynch syndrome? - review
by: Agnieszka Kwiatkowska, et al.
Published: (2019-09-01)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
by: Ruriko Ono, et al.
Published: (2019-07-01)

Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high
by: Motohiro Fujiwara, et al.
Published: (2020-03-01)

Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
by: Yuki Ikeda, et al.
Published: (2021-04-01)

A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing
by: James Wei Tatt Toh, et al.
Published: (2021-06-01)

Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
by: Yusuke Kawamura, et al.
Published: (2020-10-01)

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
by: Keisuke Koroki, et al.
Published: (2021-04-01)

Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches
by: Janna Siemanowski, et al.
Published: (2021-03-01)

Higher frequency of isolated PMS2 loss in colorectal tumors in Colombian population: preliminary results
by: Shamekh R, et al.
Published: (2016-08-01)

Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
by: Neal C. Ramchander, et al.
Published: (2020-01-01)

Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients
by: Amanda Frydendahl Boll Johansen, et al.
Published: (2019-10-01)

Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
by: Jie Mei, et al.
Published: (2021-02-01)

A clinicopathologic study of endometrial cancer metastatic to bone: Identification of microsatellite instability improves treatment strategies
by: Jennifer McEachron, et al.
Published: (2020-05-01)

Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma
by: Ignacio Ruz-Caracuel, et al.
Published: (2019-11-01)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
by: Sandrine Rousset-Rouviere, et al.
Published: (2021-06-01)

Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer
by: MR Abbaszadegan, et al.
Published: (2009-09-01)

Cannot write session to /tmp/vufind_sessions/sess_nh3hbrs8ql2dkjpb5bvhvn9rtv